Centiva Capital, LP Maravai Lifesciences Holdings, Inc. Transaction History
Centiva Capital, LP
- $4.79 Billion
- Q3 2024
A detailed history of Centiva Capital, LP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Centiva Capital, LP holds 25,000 shares of MRVI stock, worth $140,250. This represents 0.0% of its overall portfolio holdings.
Number of Shares
25,000
Previous 25,021
0.08%
Holding current value
$140,250
Previous $179,000
15.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding MRVI
# of Institutions
234Shares Held
140MCall Options Held
223KPut Options Held
19.4K-
Gtcr LLC20.2MShares$113 Million13.05% of portfolio
-
12 West Capital Management LP New York, NY14MShares$78.6 Million12.14% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$66.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.73MShares$54.6 Million0.0% of portfolio
-
Braidwell LP Stamford, CT8.35MShares$46.9 Million1.97% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $738M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...